Stability Testing Before You Manufacture
Shelf life is a claim like any other. If you print a date on the bottle, someone can ask what it was based on.
Short answer
Stability testing establishes how long your product holds its declared potency, and under what storage conditions, so the expiry date on the label is a finding rather than a guess. Real-time testing stores the finished product in its final packaging at the conditions your market actually sees and tests at intervals across the full claimed shelf life — it is definitive and it takes as long as the claim. Accelerated testing runs elevated temperature and humidity to force degradation faster and support a provisional shelf life while real-time data accumulates. Both must use the finished product in its final packaging, because the container is part of the result: the same formula in a bottle, a blister, and a bottle with desiccant will give three different answers. Which climate zone you test against depends on where you sell, and a product stable in a temperate market can fail in a hot and humid one.
What stability testing actually answers
Four questions, and potency is only the first.
- Does the active still assay at label claim at the end of the shelf life you intend to print?
- Does the product still behave — does the capsule still disintegrate, does the powder still flow, has the tablet hardened, has the gummy fused?
- Is it still safe — no microbial growth, no degradation products of concern.
- Is it still saleable — color, odor, and taste shift long before potency does, and a customer returns a product that smells wrong regardless of the assay.
That last one is the commercial failure mode founders least expect. A batch that passes potency and fails appearance is still a batch you cannot sell.
Accelerated vs real-time
| Accelerated | Real-time | |
|---|---|---|
| What it does | Elevated temperature and humidity to force degradation faster | Stores at the conditions the market actually sees |
| Time required | Months | The full claimed shelf life |
| What it supports | A provisional shelf life while real-time accrues | The definitive claim |
| Main limitation | Heat can trigger degradation pathways that never occur in normal storage | Slow, which is the whole problem |
| Typical use | Launch on provisional data, confirm later | Runs in parallel from the same batch |
The normal approach is both, started from the same batch at the same time: accelerated gives you something to print, real-time eventually confirms or corrects it. What you should not do is print a shelf life derived from neither.
Packaging and climate are part of the test
The container is a variable, not a wrapper
Stability data belongs to a formula in a specific package. A bottle admits oxygen at every opening; a blister isolates each dose; desiccant changes the moisture profile entirely. Test the configuration you will actually ship, and understand that changing the packaging later is a change that may invalidate the data you based your date on.
Climate zone follows your market
Storage conditions for testing are defined by climate zone, and the temperate conditions used for a US or Northern European market are milder than the hot and humid conditions relevant to much of South and Southeast Asia. A product comfortably stable in one can degrade meaningfully faster in the other. If you sell into both, you need data for both — and warehouses and shipping containers routinely exceed the ambient conditions of either.
Hygroscopic actives are the usual culprit
Botanical extracts, some mineral salts, and many actives pull moisture from the air, which drives caking, clumping, capsule softening, and accelerated degradation. If your formula contains them, packaging and desiccant stop being cosmetic decisions and become part of whether the product works at month eighteen.
Modeling before you commit to a study
Stability studies are slow and they are not free, and the worst outcome is running one, waiting months, and learning the formula was never going to hold — because now you reformulate and start again.
Formulaite models degradation computationally before that point: which compound in the formula is the limiting one, which failure mode is likely — oxidation, hydrolysis, antioxidant depletion — and how the answer changes across packaging configurations and climate conditions. It also models what an excipient change would do. The output is not a substitute for a stability study, and it is not a regulatory document. It is a way to arrive at the study with a formula and a package that have a good chance of passing, rather than discovering the problem after six months of real time you cannot get back.
Order of operations: model first, choose the packaging, then run the study on the configuration you intend to ship. Running the study first and changing the packaging afterwards means running it again.
Frequently asked questions
Do I legally need stability data for a supplement?
You need a basis for the expiry date you print, and GMP expects your specifications to be supported. Requirements vary by market and by what you claim. Practically, the reason to have it is not only regulatory: it is what stops you shipping a product that fails at month fourteen, and it is what a serious retail or export buyer will ask for.
Can I launch on accelerated data alone?
It is common practice to launch on a provisional shelf life from accelerated data with real-time running in parallel, and it is a reasonable commercial decision. The risk you are accepting is that accelerated conditions sometimes trigger degradation pathways that would never occur in normal storage, and sometimes miss slow ones that would. Treat the provisional date as provisional and be prepared to revise it.
Does changing my packaging invalidate my stability data?
Potentially, yes, and this catches people out at exactly the wrong moment — usually a cost-reduction exercise after launch. The data describes a formula in a container. Moving from a bottle with desiccant to one without, or from a blister to a bottle, changes the moisture and oxygen environment and may change the answer. Treat a packaging change as something to bridge with data rather than assume.
What does Formulaite's stability modeling actually produce?
A computational prediction of which compound limits your shelf life, the likely failure mode, and how that changes across packaging configurations and storage climates — including what a specific excipient change would do. It is a design tool for arriving at a study you can pass, not a replacement for the study and not a regulatory submission.
Related founder resources
Know the answer before the study tells you
Formulaite models degradation, limiting compounds, and packaging effects computationally, so the stability study you commission is one your formula can pass.